மெரில் லிஞ்ச் ஆசியா பெஸிஃபிக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மெரில் லிஞ்ச் ஆசியா பெஸிஃபிக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மெரில் லிஞ்ச் ஆசியா பெஸிஃபிக் Today - Breaking & Trending Today

[HK]恒达科技控股:联合公告(1)寄发有关金利丰证券有限公司代表香港航天科技集团有限公司作出的强制性无条件现金要约以收购恒达科技控股有限公司全部已发行股份(除要约人及╱或与其一致行动人士已拥有及.- CFi.CN 中财网

[HK]恒达科技控股:联合公告(1)寄发有关金利丰证券有限公司代表香港航天科技集团有限公司作出的强制性无条件现金要约以收购恒达科技控股有限公司全部已发行股份(除要约人及╱或与其一致行动人士已拥有及.- CFi.CN 中财网
cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , United Kingdom , Chen Wei , City Of , Cayman Islands , Lee Kennedy , Hong Kong Cyberport , Stuttgart Securities Exchange , Technology Group Limited , Technology Holdings Limited In Cayman , Canada University Of Ottawa Science , Stock Exchange , Hong Kong Aerospace Science , United Kingdom Kingdoma University , Taiwana National , Home Affairs Department Building Management , Crown Universal Group , Hong Kong University Revised College Hons , Shanghai Securities Exchange , Switzerland Bank Liao Mr , Jazz Trust The Fund , Management Societyd Member , Council The Independent Finance Consultant Yan , London Securities Exchange , Merrill Lynch Asia Pacific ,

Harbour BioMed Completes Its Global Offering and Listing on the Hong Kong Stock Exchange


Harbour BioMed Completes Its Global Offering and Listing on the Hong Kong Stock Exchange
CAMBRIDGE, Mass. and SUZHOU, China, Dec. 17, 2020 /PRNewswire/ HBM Holdings Limited ( Harbour BioMed , HBM or the Company ; Stock Code: 02142.HK), a global clinical-stage biopharmaceutical company, completed its global offering (the Global Offering ) and its listing on the Main Board of the Stock Exchange of Hong Kong Limited (the Stock Exchange ). The number of offer shares under the Global Offering is a total of 138,221,000 shares at a price of HK $12.38 per share, raising HK$1,711 million (USD$221 million) in total (before exercise of the over-allotment option in connection with the Global Offering). The offering was completed on December 10 ....

United States , Hong Kong , District Of Columbia , United Kingdom , United Kingdom General , Jingsong Wang , Anlan Fund , Morgan Stanley Asia , Capital Markets , China International Capital Corporation Hong Kong Securities , Blackrock Fund , Credit Suisse Hong Kong , Merrill Lynch Far East , Hong Kong Stock Exchange , Holdings Limited The Company In Hong Kong , Orbimed Fund , Holdings Limited Harbour Biomed , Merrill Lynch Asia Pacific , Stock Code , Main Board , Stock Exchange , Hong Kong Limited , Global Offering , Stanley Asia Limited , Merrill Lynch Far East Limited , Markets Limited ,